Factor V (Factor 5) is a protein in your blood that helps form clots when you’re injured. It’s produced primarily by liver cells and plays a central role in the clotting cascade, the chain reaction your body triggers to stop bleeding. Most people search for Factor V because they’ve heard of Factor V Leiden, a common genetic mutation that makes blood clot too easily, but Factor V itself is simply a normal and necessary part of how your body controls bleeding.
How Factor V Works in Blood Clotting
When you cut yourself or damage a blood vessel, your body launches a series of steps to seal the wound. Factor V is part of the final stretch of that process, called the common pathway. Here’s the short version: Factor V teams up with another clotting protein called Factor X to form what’s known as the prothrombinase complex. This complex converts an inactive protein (prothrombin) into thrombin, which is the enzyme that actually builds the fibrin mesh holding a clot together.
Factor V doesn’t do the cutting itself. It acts as a cofactor, essentially a helper molecule that makes Factor X work faster and more efficiently. Before it can do this job, Factor V needs to be switched on. Both thrombin and Factor X can activate it by clipping off a portion of the protein. This creates an interesting feedback loop: thrombin, the end product, circles back to activate more Factor V, which produces more thrombin. That positive feedback is what allows clots to form rapidly at a wound site rather than building up slowly.
Once the clot has done its job, your body needs a way to shut Factor V down so clotting doesn’t spiral out of control. A protein called activated protein C (APC) is responsible for breaking down Factor V and turning off its activity. This on/off balance is critical. Problems with either side of it, too little Factor V or Factor V that won’t turn off, lead to the two main medical conditions associated with this protein.
Factor V Leiden: The Clotting Mutation
Factor V Leiden is the most common inherited clotting disorder in people of European descent. It’s caused by a single change in the gene that codes for Factor V, located on chromosome 1. That one-letter swap in the DNA produces a version of Factor V that resists being broken down by activated protein C. In practical terms, the “off switch” doesn’t work properly, so activated Factor V stays in the bloodstream longer than it should, promoting excess clotting.
You can inherit one copy of the mutation (heterozygous) or two copies (homozygous). Carrying one copy increases your lifetime risk of developing a blood clot by about 7 times compared to someone without the mutation. Carrying two copies, which is rare, raises that risk roughly 20-fold. The clots that form are typically venous, meaning they occur in the deep veins of the legs (deep vein thrombosis) or travel to the lungs (pulmonary embolism).
Many people with one copy of Factor V Leiden never develop a clot in their lifetime. The mutation raises the baseline risk, but other factors stack on top of it: prolonged immobility, surgery, pregnancy, oral contraceptives, and obesity all add to the likelihood. Someone with the mutation who never encounters these additional triggers may go through life without knowing they carry it. That’s why Factor V Leiden is often discovered only after a person has an unexplained clot, especially at a young age or in an unusual location.
Factor V Deficiency: The Bleeding Disorder
On the opposite end of the spectrum, some people don’t produce enough Factor V. Congenital Factor V deficiency, sometimes called parahemophilia or Owren’s disease, is extremely rare, affecting roughly one in a million people. Without adequate Factor V, the prothrombinase complex can’t form efficiently, and clot formation slows down or fails.
Symptoms vary widely. Some people with low Factor V levels are completely asymptomatic. Others experience mucosal bleeding, the most common presentation, which includes frequent nosebleeds and unusually heavy menstrual periods. About 40% of diagnosed patients report these mucosal symptoms. More severe cases can involve easy bruising, tiny red spots on the skin from bleeding under the surface, or in rare instances, life-threatening hemorrhage.
How Factor V Levels Are Tested
Factor V activity is measured with a blood test that reports results as a percentage of normal function. For adults, the normal range is 62% to 140%. Newborns have a wider and lower range (36% to 108% in the first four days of life), which gradually rises and stabilizes through childhood.
If a doctor suspects Factor V deficiency, the first clue usually comes from two routine clotting tests: the PT and the aPTT (tests that measure how long it takes blood to clot through different pathways). When both are prolonged, it suggests a problem in the common pathway where Factor V operates. A mixing study follows: the patient’s blood is combined with normal blood. If clotting times return to normal in the mix, the issue is a factor deficiency rather than an antibody attacking a clotting factor. A specific Factor V activity assay then confirms the diagnosis.
Testing for Factor V Leiden is different. It’s a genetic test, either a blood test looking for APC resistance or a DNA test that identifies the specific mutation directly. This test is typically ordered after an unexplained clot, a clot in someone under 50, recurrent clots, or clots during pregnancy.
Living With a Factor V Condition
For people with Factor V Leiden, management depends on whether you’ve actually had a clot. Carriers who have never clotted generally don’t need daily treatment, but they benefit from being aware of situational risks. That means discussing the mutation with your doctor before surgery, during pregnancy planning, or when considering hormone-based contraceptives. After a first clot, blood thinners are the standard treatment, with the duration depending on whether the clot had a clear trigger or appeared spontaneously.
For Factor V deficiency, treatment focuses on preventing or controlling bleeding episodes. Since there is no concentrated Factor V product available, fresh frozen plasma is the typical source of replacement Factor V during significant bleeding or before surgical procedures. People with mild deficiency often need no regular treatment at all and simply take precautions around surgeries or dental work.
In both conditions, knowing your Factor V status gives you and your healthcare team the information needed to reduce risk in high-stakes situations. For Factor V Leiden carriers especially, awareness is often the most powerful tool: understanding that long flights, immobility after surgery, or certain medications shift your risk profile allows you to take straightforward preventive steps like staying hydrated, moving regularly, and having honest conversations with your doctors before medical procedures.